VRTX- Vertex Pharmaceuticals Incorporated

Name: Vertex Pharmaceuticals Incorporated Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 40 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kewalramani Reshma	133.5K	$60.29M	-
COO	Arbuckle Stuart A	63.4K	$28.62M	-
VP	Wagner Charles F Jr	51.1K	$23.07M	-
VP	Tatsis Ourania	42.3K	$19.10M	-
Other	Leiden Jeffrey M	24.0K	$10.85M	-

Activity

Buys and sells only

Transactions

10 filings · page 27

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Aug 6, 2020	Altshuler David48	EVP, Global Research And CSO	Sale+OE	1,223	$271.19	$331,662.77	-1.4%
Aug 6, 2020	Silva Paul M	SVP &Controller	Sale+OE	1,078	$271.17	$292,318.85	-1.7%
Aug 6, 2020	Parini Michael	EVP, Chief Adm, Leg &Bd Off	Sale+OE	1,223	$271.20	$331,672.43	-1.5%
Aug 6, 2020	Kewalramani Reshma55	CEO &President	Sale+OE	2,073	$271.20	$562,204.97	-1.5%
Aug 3, 2020	Arbuckle Stuart A	EVP, Chief Commercial Officer	Sale+OE	1,553	$278.39	$432,336.93	-1.1%
Aug 3, 2020	Altshuler David48	EVP, Global Research And CSO	Sale+OE	2,330	$278.24	$648,290.05	-1.9%
Aug 3, 2020	Sachdev Amit	EVP, Chief Patient Officer	Sale+OE	1,941	$278.28	$540,136.68	-1.8%
Aug 3, 2020	Silva Paul M	SVP &Controller	Sale+OE	809	$278.30	$225,141.57	-1.3%
Aug 3, 2020	Parini Michael	EVP, Chief Adm, Leg &Bd Off	Sale+OE	2,330	$278.28	$648,402.30	-2.7%
Jul 13, 2020	Silva Paul M	SVP &Controller	Sale+OE	860	$292.03	$251,144.60	-0.8%

← PrevPage 27Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC